¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
4/2 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2022-04-01
Á¶È¸¼ö
175


¾È³çÇϼ¼¿ä.

À̹ø ³í¹®Àº 2020³â Cell report ¿¡ ÃâÆÇµÈ 'Continued Bcl6 Expression Prevents the Transdifferentiation of Established Tfh Cells into Th1 Cells during Acute Viral Infection' ÀÔ´Ï´Ù.

Follicular helper T cell (Tfh)Àº humoral immunity ¿¡ À־ Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÏ°í ÀÖÀ¸¸ç ƯÈ÷ GCBC response ¿Í antibody Çü¼º¿¡ ÇʼöÀûÀ̶ó°í ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.

±âÁ¸¿¡ CXCR5 ´Â follicular helper T cell ÀÇ phenotype marker »Ó¸¸ ¾Æ´Ï¶ó ±â´ÉÀûÀ¸·Îµµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù°í ¾Ë·ÁÁ® ÀÖ¾úÁö¸¸

CXCR5 deficient »óȲ¿¡¼­µµ humoral immunity ÀÇ ±â´ÉÀº Å« Â÷ÀÌ°¡ ¾øÁö¸¸
master transcription factor ·Î ¾Ë·ÁÁø bcl6 °¡ ¾øÀ» °æ¿ì¿¡´Â ±â´ÉÀûÀÎ °áÇÔ»Ó¸¸ ¾Æ´Ï¶ó Th1 À¸·ÎÀÇ transdifferentiation À» À¯µµÇÑ´Ù´Â °ÍÀ» ¹àÈù ³í¹®ÀÔ´Ï´Ù.

Á¦ ¿¬±¸¿¡¼­ ³í¸®Àû È帧°ú ¹æÇ⼺ ¼±Á¤¿¡ µµ¿òÀ» ¾ò°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù.

¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.

- µµºó ¿Ã¸²
 
³í¹®¸µÅ© : https://www.cell.com/cell-reports/fulltext/S2211-1247(20)31221-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124720312213%3Fshowall%3Dtrue

÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
4/9 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº2021 ³âScience ¿¡ ÃâÆÇµÈ "Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice" ÀÔ´Ï´Ù. º» ³í¹®Àº SARS-CoV, SARS-CoV-2 ¸¦ Æ÷ÇÔÇÏ´Â Sarbecovirus ¿¡ ´ëÇÑ ¹ü¿ë¹é½ÅÀ» °³¹ßÇϱâ À§ÇØ chimeric spike designs ¸¦..
ÀÌÀü±Û
4/2 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. ¿µÁø ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ Åä¿äÀÏ¿¡ ¹ßÇ¥ ÇÒ ³í¹®Àº ¿ÃÇØ JACI¿¡ ÃâÆÇµÈ "LAIR-1 acts as an immune checkpoint onactivated ILC2s and regulates the induction ofairway hyperreactivity" ÀÔ´Ï´Ù. Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1)´Âinhibitory receptor Áß ÇÏ..